Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autism spectrum disorders: emerging pharmacotherapy.

Jeff Q Bostic1, Bryan H King

  • 1Harvard Medical School, Boston, MA, USA.

Expert Opinion on Emerging Drugs
|August 9, 2005
PubMed
Summary

Autism spectrum disorders (ASDs) present significant challenges in social interaction and behavior. This review explores current and emerging pharmacotherapies to improve treatment for these pervasive developmental disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overlap of genetic factors among craniosynostosis and autism spectrum disorder: the presence of autistic cases without craniosynostosis in carriers of shared variants.

Journal of neurosurgery. Pediatrics·2025
Same author

Research Agenda in Childhood Impairing Emotional Outbursts: A Report of the AACAP Presidential Taskforce on Emotional Dysregulation.

JAACAP open·2025
Same author

Predictors of Placebo Response in the Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors.

Journal of child and adolescent psychopharmacology·2025
Same author

Autism Spectrum Disorder: A Review.

JAMA·2023
Same author

Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.

Autism research : official journal of the International Society for Autism Research·2023
Same author

Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms.

Journal of autism and developmental disorders·2022

Area of Science:

  • Neurodevelopmental Disorders
  • Pharmacology
  • Clinical Psychiatry

Background:

  • Autism spectrum disorders (ASDs), including Asperger syndrome and pervasive developmental disorders (PDDs), are increasingly diagnosed.
  • These conditions are characterized by difficulties in social interaction, communication, and repetitive behaviors.
  • Early diagnosis (around 15 months) is possible, but ASDs often represent a chronic lifelong burden.

Purpose of the Study:

  • To review existing and novel pharmacotherapies for autism spectrum disorders.
  • To identify potential advancements in pharmacological treatments for PDDs.
  • To address the urgent need for more effective treatments targeting core ASD features.

Main Methods:

  • Literature review of current and emerging pharmacotherapies.
  • Analysis of pharmacological approaches for symptom management in PDDs.
  • Exploration of treatments for core autism spectrum disorder features.

Main Results:

  • Current pharmacotherapies primarily manage specific symptoms rather than core ASD features.
  • Several emerging pharmacotherapies show promise for advancing care.
  • No curative treatments currently exist for autism spectrum disorders.

Conclusions:

  • There is a critical need for more effective pharmacotherapies for autism spectrum disorders.
  • Emerging treatments offer hope for improving the quality of life for individuals with PDDs.
  • Further research into novel pharmacotherapies is essential for better management of ASDs.

Related Experiment Videos